N-Cyclohexylmethylone
N-Cyclohexylmethylone (cyputylone) is a substituted cathinone derivative with stimulant effects which has been sold as a designer drug. It was first identified in the United States in 2022.[1][2]
![]() | |
| Clinical data | |
|---|---|
| Other names | Cyputylone |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| PubChem CID | |
| UNII | |
| Chemical and physical data | |
| Formula | C16H21NO3 |
| Molar mass | 275.348 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
See also
References
- CFSRE (2022) N-Cyclohexyl methylone
- Kuropka P, Zawadzki M, Szpot P (September 2022). "A review of synthetic cathinones emerging in recent years (2019-2022)". Forensic Toxicology. 41 (1): 25–46. doi:10.1007/s11419-022-00639-5. PMC 9476408. PMID 36124107.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
